REDCARE PHARMACY INH. overview

EQS-News: Redcare Pharmacy N.V. / Key word(s): Issue of Debt/Financing Redcare successfully executes placement of new convertible bonds and buys back part of the outstanding convertible bonds. 08.04.2025 / 23:45 CET/CEST The issuer is solely responsible for the content of this announcement. THIS ANNOUNCEMENT, INCLUDING THE INFORMATION INCLUDED HEREIN, IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA,...

EQS-Ad-hoc: Redcare Pharmacy N.V. / Key word(s): Issue of Debt/Financing Redcare Pharmacy N.V. successfully places EUR 300 million convertible bonds and repurchases part of its outstanding EUR 225 million 0.00% convertible bonds due 2028 08-Apr-2025 / 23:21 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group. The issuer is solely responsible for the content of this announcement. THIS...

EQS-Ad-hoc: Redcare Pharmacy N.V. / Key word(s): Issue of Debt/Financing Redcare Pharmacy N.V. launches EUR 300m convertible bonds and invites holders of its outstanding EUR 225m convertible bonds due 2028 to tender their bonds for cash 08-Apr-2025 / 17:49 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group. The issuer is solely responsible for the content of this announcement. THIS ANNOUNCEMENT,...

EQS-News: Redcare Pharmacy N.V. / Key word(s): Development of Sales/Preliminary Results Redcare Pharmacy: fast growth continues in Q1; fully-organic sales growth 28%, Rx sales in Germany up 191% and active customers up 0.6 million. 04.04.2025 / 07:30 CET/CEST The issuer is solely responsible for the content of this announcement. Redcare Pharmacy: fast growth continues in Q1; fully-organic sales growth 28%, Rx sales in Germany up 191% and active customers up 0.6 million. Group sales up 28% or EUR...

EQS-News: Redcare Pharmacy N.V. / Key word(s): AGM/EGM Michael Köhler and Stephan Weber nominated for the Supervisory Board of Redcare Pharmacy. 02.04.2025 / 08:00 CET/CEST The issuer is solely responsible for the content of this announcement. Michael Köhler and Stephan Weber nominated for the Supervisory Board of Redcare Pharmacy. Sevenum, 2 April 2025. At Redcare Pharmacy’s upcoming Annual General Meeting (AGM) on 15 May 2025, changes to the composition of the Supervisory Board will be on...

EQS-News: Redcare Pharmacy N.V. / Key word(s): Annual Results/Forecast Building on a successful 2024, Redcare Pharmacy expects margin uplift and unabated fast growth in 2025, including a doubling of Rx. 11.03.2025 / 06:30 CET/CEST The issuer is solely responsible for the content of this announcement. Building on a successful 2024, Redcare Pharmacy expects margin uplift and unabated fast growth in 2025, including a doubling of Rx. Total sales +32% to EUR 2.4 bn in FY 2024 (Q4, +27%), with DACH...

EQS-News: Redcare Pharmacy N.V. / Key word(s): Statement Positive judgment of the European Court of Justice strengthens the position of Redcare Pharmacy and its customers. 27.02.2025 / 12:15 CET/CEST The issuer is solely responsible for the content of this announcement. Positive judgment of the European Court of Justice strengthens the position of Redcare Pharmacy and its customers. Sevenum, the Netherlands, 27 February 2025 – Redcare Pharmacy welcomes today's judgment of the European Court of...

EQS-News: Redcare Pharmacy N.V. / Key word(s): Development of Sales/Preliminary Results Redcare Pharmacy completes an exceptional year across the Group: 2024 sales up 32% to EUR 2.4bn, with Rx growth in Germany accelerating to 142% in Q4. 09.01.2025 / 06:45 CET/CEST The issuer is solely responsible for the content of this announcement. Redcare Pharmacy completes an exceptional year across the Group: 2024 sales up 32% to EUR 2.4bn, with Rx growth in Germany accelerating to 142% in Q4. Full-year...